AI/ML
Pharmacometrics has evolved into an important discipline by developing novel mathematical modeling approaches and in-silico simulations to support drug development and accelerate market access of safe and efficacious therapies. Sponsored by the ISoP-ASA Statistics and Pharmacometrics Special Interest Group (SxP SIG), the Artificial Intelligence and Machine Learning Special Interest Sub-Group (AI/ML SubSIG) was created with the goal to promote a forum dedicated to fostering the advancement and application of AI/ML methods and to facilitate the integration of AI/ML approaches within pharmacometrics by supporting their development, use, and education.
For any queries, please contact either souvik.bhattacharya@astellas.com or akash.khandelwal@ucb.com.
Co-Chairs
- Souvik Bhattacharya
- Akash Khandelwal
Objectives
Create and foster and environment to promote the use of AI/ML in drug development.
- Facilitate interactions between individual users and subject matter experts
Promote training and dissemination of ideas and experiences.
- Plan webinars and sessions at major conferences